Lung cancer screening: New guidelines, new challenges

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Smoking is still the number one preventable cause of death in the U.S.​ and lung cancer is far and away the number one cause of cancer death in the U.S. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
David Balis, MD
Professor, general internal medicine, Department of Internal Medicine, UT Southwestern Medical Center; Director, Smoking Cessation Clinics, Parkland and UT Southwestern
Table of Contents

YOU MAY BE INTERESTED IN

Twenty years ago, the discovery of epidermal growth factor receptor mutations as drivers of tumorigenesis and viable targets for therapeutic intervention marked the beginning of a new era in lung cancer diagnosis and treatment. Since then, the field has made remarkable progress towards developing more effective targeted treatments and immunotherapies that have significantly improved patient outcomes and survival.
David Balis, MD
Professor, general internal medicine, Department of Internal Medicine, UT Southwestern Medical Center; Director, Smoking Cessation Clinics, Parkland and UT Southwestern

Login